NXGN Insider Trading Activity and SEC Form 4 Filings
NXGN insider trading summary
No open-market insider purchases or sales of Nextgen Healthcare, Inc. (NXGN) have been reported on SEC Form 4 in the past 12 months.
Latest NXGN insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 1, 2022 | David A Metcalfe | Chief Technology Officer | Sell | $666K (32,372 @ $20.58) |
| Nov 8, 2022 | Mitchell Waters | EVP, Commercial Growth | Sell | $201K (9,783 @ $20.50) |
| Nov 1, 2022 | David A Metcalfe | Chief Technology Officer | Sell | $647K (32,372 @ $20.00) |
| Oct 26, 2022 | Mitchell Waters | EVP, Commercial Growth | Sell | $78K (3,889 @ $20.00) |
| Oct 26, 2022 | David A Metcalfe | Chief Technology Officer | Sell | $654K (32,372 @ $20.21) |
| Sep 1, 2022 | Craig A. Barbarosh | Director | Sell | $60K (3,500 @ $17.27) |
| Aug 1, 2022 | Craig A. Barbarosh | Director | Sell | $61K (3,500 @ $17.35) |
| Jul 1, 2022 | Craig A. Barbarosh | Director | Sell | $61K (3,500 @ $17.39) |
| Jun 1, 2022 | Craig A. Barbarosh | Director | Sell | $64K (3,500 @ $18.17) |
| May 3, 2022 | David A Metcalfe | Chief Technology Officer | Sell | $677K (33,838 @ $20.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.